Human Papillomavirus Vaccine against Cervical Cancer: New Usage Strategies and Coverage Issues
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 20 October 2024 | Viewed by 418
Special Issue Editors
Interests: pathology of the lower genital tract disease; HPV related disaese; HPV vaccination; HPV genotype distribution
Special Issues, Collections and Topics in MDPI journals
Interests: pathology of the lower genital tract disease; HPV related disease; HPV vaccination; HPV genotype distribution
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cervical cancer (CC) represents one of the most common female cancers worldwide, with 80% of cases originating from developing countries. These data are surprising given that CC is the only tumor that has primary and secondary prevention. The WHO has set goals for its elimination by 2030, proposing a vaccination coverage of 90%. In many countries worldwide, the vaccination coverage is well below this set goal. Hence, there is a need to implement vaccination coverage.
This Special Issue aims to provide evidence regarding the use of the HPV vaccine in different settings. Adolescent girls represent the primary target, but its use after excisional or definitive treatments is a trending topic of interest. Furthermore, the tools necessary for its implementation aimed at women of screening age or parents with daughters of vaccination age are topics of crucial interest.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: HPV vaccination coverage in developed and developing countries, HPV vaccination after conization, HPV vaccination after hysterectomy for cervical pathology, the role of HPV vaccination after fertility-sparing treatment, HPV vaccination in male, HPV vaccination in vaginal and vulvar pathology, and HPV genotype distribution in cervical pathology according to age.
We look forward to receiving your contributions.
Dr. Luca Giannella
Dr. Andrea Ciavattini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV vaccination coverage
- HPV vaccination after conization
- HPV vaccination in fertility-sparing treatment
- male HPV vaccination HPV
- vaccination after hysterectomy
- tools for HPV vaccination implementation
- HPV genotype in pre-invasive and invasive cervical pathology
- HPV vaccination in vaginal pathology
- HPV vaccination in vulvar pathology
